Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation

Gene

Volumn 245, Issue 2, 2000, Pages 223-235

  Lutterbach, B ^a   Hiebert, S W ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deacetylation; Myeloid; Runt; Transcriptional repression

Indexed keywords

TRANSCRIPTION FACTOR;

ACUTE LEUKEMIA; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CHROMOSOME TRANSLOCATION; DEACETYLATION; HEMATOPOIETIC CELL; HOMEOSTASIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ACUTE DISEASE; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0034696627     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00014-7     Document Type: Review

References (133)

1. Adya N., Stacy T., Speck N.A., Liu P.P. The leukemic protein core binding factor beta (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFA2 into cytoskeletal filaments and aggregates. Mol. Cell. Biol. 18:1998;7432-7443.
2. Ahn M.Y., Huang G., Bae S.C., Wee H.J., Kim W.Y., Ito Y. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up and a chimeric leukemogenic gene, AML1/ETO. Proc. Natl. Acad. Sci. USA. 95:1998;1812-1817.
3. Aronson B.D., Fisher A.L., Blechman K., Caudy M., Gergen J.P. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell. Biol. 17:1997;5581-5587.
4. Banerjee C., McCabe L.R., Choi J.Y., Hiebert S.W., Stein J.L., Stein G.S., Lian J.B. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem. 66:1997;1-8.
5. Banker D.E., Radich J., Becker A., Kerkof K., Norwood T., Willman C., Appelbaum F.R. The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. Clin. Cancer Res. 4:1998;3051-3062.
6. Bruhn L., Munnerlyn A., Grosschedl R. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function. Genes Dev. 11:1997;640-653.
7. Campbell B.A., Villarreal L.P. Functional analysis of the individual enhancer core sequences of polyomavirus: cell-specific uncoupling of DNA replication from transcription. Mol. Cell. Biol. 8:1988;1993-2004.
8. Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 87:1996;687-696.
9. Castilla L.H., Garrett L., Adya N., Orlic D., Dutra A., Anderson S., Owens J., Eckhaus M., Bodine D., Liu P.P. The fusion gene CBFβ-MYH11 blocks myeloid differentiation and predisposes mice to myelomonocytic leukemia. Nat. Genet. 23:1999;144-146.
10. Chakrabarti S.R., Sood R., Ganguly S., Bohlander S., Shen Z., Nucifora G. Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. Proc. Natl. Acad. Sci. USA. 96:1999;7467-7472.
11. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
12. Chen L.F., Ito K., Murakami Y., Ito Y. The capacity of polyomavirus enhancer binding protein 2αB (AML1/Cbfα2) to stimulate polyomavirus DNA replication is related to its affinity for the nuclear matrix. Mol. Cell. Biol. 18:1998;4165-4176.
13. Chen Z., Brand N.J., Chen A., Chen S.J., Tong J.H., Wang Z.Y., Waxman S., Zelent A. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. Embo J. 12:1993;1161-1167.
14. Daga A., Karlovich C.A., Dumstrei K., Banerjee U. Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes Dev. 10:1996;1194-1205.
15. Dikstein R., Zhou S., Tjian R. Human TAFII 105 is a cell type-specific TFIID subunit related to hTAFII130. Cell. 87:1996;137-146.
16. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 89:1997;747-754.
17. Duffy J.B., Gergen J.P. The Drosophila segmentation gene runt acts as a position-specific numerator element necessary for the uniform expression of the sex-determining gene sex-lethal. Genes Dev. 5:1991;2176-2187.
18. Duffy J.B., Kania M.A., Gergen J.P. Expression and function of the Drosophila gene runt in early stages of neural development. Development. 113:1991;1223-1230.
19. Dutta A., Ruppert J.M., Aster J.C., Winchester E. Inhibition of DNA replication factor RPA by p53. Nature. 365:1993;79-82.
20. Eastman Q., Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr. Opin. Cell. Biol. 11:1999;233-240.
21. Erickson P., Gao J., Chang K.S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J., Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML-1/ETO, with similarity to Drosophila segmentation gene, runt. Blood. 80:1992;1825-1831.
22. Erickson P.F., Dessev G., Lasher R.S., Philips G., Robinson M., Drabkin H.A. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood. 88:1996;1813-1823.
23. Erman B., Cortes M., Nikolajczyk B.S., Speck N.A., Sen R. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Mol. Cell. Biol. 18:1998;1322-1330.
24. Feinstein P.G., Kornfeld K., Hogness D.S., Mann R.S. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics. 140:1995;573-586.
25. Fenrick R., Amann J., Lutterbach B., Wang L., Westendorf J., Downing J.R., Hiebert S.W. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol. Cell. Biol. 10:1999;6566-6574.
26. Fisher A.L., Ohsako S., Caudy M. The WRPW motif of the hairy-related basic helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain. Mol. Cell. Biol. 16:1996;2670-2677.
27. Frank R., Zhang J., Uchida H., Meyers S., Hiebert S.W., Nimer S.D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene. 11:1995;2667-2674.
28. Gamou T., Kitamura E., Hosoda F., Shimizu K., Shinohara K., Hayashi Y., Nagase T., Yokoyama Y., Ohki M. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood. 91:1998;4028-4037.
29. Gelmetti V., Zhang J., Fanelli M., Minucci S., Pelicci P.G., Lazar M.A. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18:1998;7185-7191.
30. Gergen J.P., Wieschaus E. Dosage requirements for runt in the segmentation of Drosophila embryos. Cell. 45:1986;289-299.
31. Giese K., Kingsley C., Kirshner J.R., Grosschedl R. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:1995;995-1008.
32. Golling G., Li L., Pepling M., Stebbins M., Gergen J.P. Drosophila homologs of the proto-oncogene product PEBP2/CBFβ regulate the DNA-binding properties of Runt. Moll. Cell. Biol. 16:1988;932-942.
33. Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C., Bray-Ward P., Morgan E., Raimondi S.C., Rowley J.D., Gilliland D.G. Fusion of the TEL gene on 12p13 to the AML1 gene on 2 1q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA. 92:1995;4917-4921.
34. Gross C.T., McGinnis W. DEAF-1, a novel protein that binds an essential region in a deformed response element. Embo J. 15:1996;1961-1970.
35. Guo Z.S., DePamphilis M.L. Specific transcription factors stimulate simian virus 40 and polyomavirus origins of DNA replication. Mol. Cell. Biol. 12:1992;2514-2524.
36. He Z., Brinton B.T., Greenblatt J., Hassell J.A., Ingles C.J. The transactivator proteins VP16 and GAL4 bind replication factor A. Cell. 73:1993;1223-1232.
37. Hernandez-Munain C., Krangel M.S. Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors. Mol. Cell. Biol. 14:1994;473-483.
38. Hiebert S.W., Sun W., Davis J.N., Golub T., Shurtleff S., Buijs A., Downing J.R., Grosveld G., Roussell M.F., Gilliland D.G., Lenny N., Meyers S. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16:1996;1349-1355.
39. Higashijima S., Kojima T., Michiue T., Ishimaru S., Emori Y., Saigo K. Dual Bar homeobox genes of Drosophila required in two photoreceptor cells, R1 and R6, and primary pigment cells for normal eye development. Genes Dev. 6:1992;50-60.
40. Hoey T., Weinzierl R.O., Gill G., Chen J.L., Dynlacht B.D., Tjian R. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell. 72:1993;247-260.
41. Hohaus S., Petrovick M.S., Voso M.T., Sun Z., Zhang D.E., Tenen D.G. PU.1 (Spi-1) and C/EBPα regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol. Cell. Biol. 15:1995;5830-5845.
42. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
43. Huang X., Peng J.W., Speck N.A., Bushweller J.H. Solution structure of core binding factor beta and map of the CBFα binding site. in process citation Nat. Struct. Biol. 6:1999;624-627.
44. Imai Y., Kurokawa M., Tanaka K., Friedman A.D., Ogawa S., Mitani K., Yazaki Y., Hirai H. TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML 1-induced transactivation. Biochem. Biophys. Res. Commun. 252:1998;582-589.
45. Jeppesen P. Histone acetylation: a possible mechanism for the inheritance of cell memory at mitosis. Bioessays. 19:1997;67-74.
46. Jimenez G., Pinchin S.M., Ish-Horowicz D. In vivo interactions of the Drosophila Hairy and Runt transcriptional repressors with target promoters. Embo J. 15:1996;7088-7098.
47. Kamachi Y., Ogawa E., Asano M., Ishida S., Murakami Y., Satake M., Ito Y., Shigesada K. Purification of a mouse nuclear factor that binds to both the A and B cores of the Polyomavirus enhancer. J. Virol. 64:1990;4808-4819.
48. Kania M.A., Bonner A.S., Duffy J.B., Gergen J.P. The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system. Genes Dev. 4:1990;1701-1713.
49. Kanno Y., Kanno T., Sakakura C., Bae S.C., Ito Y. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFα) subunit by the leukemia-related PEBP2/CBFβ-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. Mol. Cell. Biol. 18:1998;4252-4261.
50. Kim W.Y., Sieweke M., Ogawa E., Wee H.J., Englmeier U., Graf T., Ito Y. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. Embo J. 18:1999;1609-1620.
51. Kinashi T., Lee K.H., Ogawa M., Tohyama K., Tashiro K., Fukunaga R., Nagata S., Honjo T. Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture. J. Exp. Med. 173:1991;1267-1279.
52. Kitabayashi I., Ida K., Morohoshi F., Yokoyama A., Mitsuhashi N., Shimizu K., Nomura N., Hayashi Y., Ohki M. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1. Mol. Cell. Biol. 18:1998;846-858.
53. Kitabayashi I., Yokoyama A., Shimizu K., Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. Embo J. 17:1998;2994-3004.
54. Klampfer L., Zhang J., Zelenetz A.O., Uchida H., Nimer S.D. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA. 93:1996;14 059-14 064.
55. Kogan S.C., Lagasse E., Atwater S., Bae S.C., Weissman I., Ito Y., Bishop J.M. The PEBP2betaMYH 11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc. Natl. Acad. Sci. USA. 95:1998;11 863-11 868.
56. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of CbfA1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
57. Kwiatkowski B.A., Bastian L.S., Bauer T.R. Jr, Tsai S., Zielinska-Kwiatkowska A.G., Hickstein D.D. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273:1998;17 525-17 530.
58. Lagasse E., Weissman I.L. Mouse MRP8 and MRP 14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood. 79:1992;1907-1915.
59. Lenny N., Meyers S., Hiebert S.W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene. 11:1995;1761-1769.
60. Lenny N., Westendorf J.J., Hiebert S.W. Transcriptional regulation during myelopoiesis. Mol. Biol. Rep. 24:1997;157-168.
61. Levanon D., Negreanu V., Bernstein Y., Bar-Am I., Avivi L., Groner Y. AML 1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics. 23:1994;425-432.
62. Levanon D., Bernstein Y., Negreanu V., Ghozi M.C., Bar-Am I., Aloya R., Goldenberg D., Lotem J., Groner Y. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 15:1996;175-185.
63. Levanon D., Goldstein R.E., Bernstein Y., Tang H., Goldenberg D., Stifani S., Paroush Z., Groner Y. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA. 95:1998;11590-11595.
64. Li R., Botchan M.R. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell. 73:1993;1207-1221.
65. Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., Collins F.S. Fusion between transcription factor CBFβ/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 261:1993;1041-1044.
66. Lutterbach B., Sun D., Schuetz J., Hiebert S.W. The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol. Cell. Biol. 18:1998;3604-3611.
67. Lutterbach B., Westendorf J.J., Linggi B., Patten A., Moniwa M., Davie J.R., Huynh K.D., Bardwell V.J., Lavinsky R.M., Glass C.K., Rosenfeld M.G., Seto E., Hiebert S.W. ETO, a target of the t(8;21) in acute leukemia, interacts with N-CoR, mSin3 and histone deacetylases. Mol. Cell. Biol. 18:1998;7176-7184.
68. Lutterbach B., Durst K., Hou Y., Hiebert S.W. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc. Natl. Acad. Sci. USA. 96:1999;12 822-12 827.
69. Lutterbach B., Westendorf J.J., Linggi B., Seto E., Hiebert S.W. A mechanism of transcriptional repression by AML-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275:2000;651-656.
70. Manoukian A.S., Krause H.M. Control of segmental asymmetry in Drosophila embryos. Development. 118:1993;785-796.
71. Mao S., Frank R.C., Zhang J., Miyazaki Y., Nimer S.D. Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias. Mol. Cell. Biol. 19:1999;3635-3644.
72. Melnick A.M., Westendorf J.J., Polinger A., Carlisle G., Arai S., Lutterbach B., Hiebert S.W., Licht J.D. ETO, a target of the t(8;21) AML translocation, is a co-repressor for PLZF, a transcription factor disrupted in t(11;17) APL. Mol. Cell. Biol. 19:2000;. in press.
73. Merriman H.L., van Wijnen A.J., Hiebert S., Bidwell J.P., Fey E., Lian J., Stein J., Stein G.S. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry. 34:1995;13 125-13 132.
74. Meyers S., Hiebert S.W. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit. Rev. Euk. Gene Express. 5:1995;365-383.
75. Meyers S., Downing J.R., Hiebert S.W. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13:1993;6336-6345.
76. Meyers S., Lenny N., Hiebert S.W. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15:1995;1974-1982.
77. Meyers S., Lenny N., Sun W., Hiebert S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene. 13:1996;303-312.
78. Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. Embo J. 13:1994;504-510.
79. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA. 88:1991;10431-10434.
80. Miyoshi H., Kozu T., Shimizu K., Enomoto K., Maseki N., Kaneko Y., Kamada N., Ohki M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. Embo J. 12:1993;2715-2721.
81. Mlodzik M., Hiromi Y., Weber U., Goodman C.S., Rubin G.M. The Drosophila seven-up gene, a member of the steroid receptor gene superfamily, controls photoreceptor cell fates. Cell. 60:1990;211-224.
82. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. see comments Cell. 89:1997;773-779.
83. Nagata T., Gupta V., Sorce D., Kim W.Y., Sali A., Chait B.T., Shigesada K., Ito Y., Werner M.H. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. in process citation Nat. Struct. Biol. 6:1999;615-619.
84. Niitsu N., Yamamoto-Yamaguchi Y., Miyoshi H., Shimizu K., Ohki M., Umeda M., Honma Y. AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth Differ. 8:1997;319-326.
85. Niki M., Okada H., Takano H., Kuno J., Tani K., Hibino H., Asano S., Ito Y., Satake M., Noda T. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA. 94:1997;5697-5702.
86. Nisson P.E., Watkins P.C., Sacchi N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet. Cytogenet. 63:1992;81-88.
87. Nuchprayoon I., Meyers S., Scott L.M., Suzow J., Hiebert S., Friedman A.D. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2α/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14:1994;5558-5568.
88. Nucifora G., Rowley J.D. The AML1 gene in the 8;21 and 3;21 translocations in chronic and acute myeloid leukemia. Cold Spring Harbor Symp. Quant. Biol. 59:1994;595-605.
89. Nucifora G., Birn D.J., Espinosa R.I., Erickson P., LeBeau M.M., Roulston D., McKeithan T.W., Drabkin H., Rowley J.D. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood. 81:1993;2728-2734.
90. Ogawa E., Inuzuka M., Maruyama M., Satake M., Naito-Fujimoto M., Ito Y., Shigesada K. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α Virology. 194:1993;314-331.
91. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
92. Okuda T., Cai Z., Yang S., Lenny N., Lyu C.J., van Deursen J.M., Harada H., Downing J.R. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood. 91:1998;3134-3143.
93. Osato M., Asou N., Abdalla E., Hoshino K., Yamasaki H., Okubo T., Suzushima H., Takatsuki K., Kanno T., Shigesada K., Ito Y. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias. Blood. 93:1999;1817-1824.
94. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
95. Petrovick M.S., Hiebert S.W., Friedman A.D., Hetherington C.J., Tenen D.G., Zhang D.E. Multiple functional domains of AML1: PU.1 and C/EBPα synergize with different regions of AML1. Mol. Cell. Biol. 18:1998;3915-3925.
96. Prosser H.M., Wotton D., Gegonne A., Ghysdael J., Wang S., Speck N.A., Owen M.J. A phorbol ester response element within the human T-cell receptor β-chain enhancer. Proc. Natl. Acad. Sci. USA. 89:1992;9934-9938.
97. Redondo J.M., Pfohl J.L., Hernandez-Munain C., Wang S., Speck N.A., Krangel M.S. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor δ and murine leukemia virus enhancers. Mol. Cell. Biol. 12:1992;4817-4823.
98. Rhoades K.L., Hetherington C.J., Rowley J.D., Hiebert S.W., Nucifora G., Tenen D.G., Zhang D.E. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA. 93:1996;11 895-11 900.
99. Romana S.P., Mauchauffe M., Le Coniat M., Chumakov I., Le Paslier D., Berger R., Bernard O.A. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 85:1995;3662-3670.
100. Sakakura C., Yamaguchi-Iwai Y., Satake M., Bae S.C., Takahashi A., Ogawa E., Hagiwara A., Takahashi T., Murakami A., Makino K., et al. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc. Natl. Acad. Sci. USA. 91:1994;11 723-11 727.
101. Sasaki K., Yagi H., Bronson R.T., Tominaga K., Matsunashi T., Deguchi K., Tani Y., Kishimoto T., Komori T. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc. Natl. Acad. Sci. USA. 93:1996;12 359-12 363.
102. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
103. Shurtleff S.A., Buijs A., Behm F.G., Rubnitz J.E., Raimondi S.C., Hancock M.L., Chan G.C., Pui C.H., Grosveld G., Downing J.R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 9:1995;1985-1989.
104. Speck N.A., Renjifo B., Golemis E., Fredrickson T.N., Hartley J.W., Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:1990;233-242.
105. Stewart M., Terry A., Hu M., O'Hara M., Blyth K., Baxter E., Cameron E., Onions D.E., Neil J.C. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA. 94:1997;8646-8651.
106. Stifani S., Blaumueller C.M., Redhead N.J., Hill R.E., Artavanis-Tsakonas S. Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat. Genet. 2:1992;343.
107. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
108. Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene. 9:1994;2145-2152.
109. Sun W., Graves B.J., Speck N.A. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:1995;4941-4949.
110. Suzow J., Friedman A.D. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol. Cell. Biol. 13:1993;2141-2151.
111. Takahashi A., Satake M., Yamaguchi-Iwai Y., Bae S.C., Lu J., Maruyama M., Zhang Y.W., Oka H., Arai N., Arai K.i., Ito Y. Positive and negative regulation of granulocyte-macrophage colony stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood. 86:1995;607-616.
112. Tanaka T., Tanaka K., Ogawa S., Kurokawa M., Mitani K., Nishida J., Shibata Y., Yazaki Y., Hirai H. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative splice forms. EMBO J. 16:1995;341-350.
113. Tanese N., Saluja D., Vassallo M.F., Chen J.L., Admon A. Molecular cloning and analysis of two subunits of the human TFIID complex: hTAF130 and hTAF100. Proc. Natl. Acad. Sci. USA. 93:1996;13 611-13 616.
114. Thirunavukkarasu K., Mahajan M., McLarren K.W., Stifani S., Karsenty G. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ Mol. Cell. Biol. 18:1998;4197-4208.
115. Tsai C., Gergen J.P. Gap gene properties of the pair-rule gene runt during Drosophila segmentation. Development. 120:1994;1671-1683.
116. Tsai C., Gergen P. Pair-rule expression of the Drosophila fushi tarazu gene: a nuclear receptor response element mediates the opposing regulatory effects of runt and hairy. Development. 121:1995;453-462.
117. Uchida H., Zhang J., Nimer S.D. AML1A and AML1B can transactivate the human IL-3 promoter. J. Immunol. 158:1997;2251-2258.
118. Uchida H., Downing J.R., Miyazaki Y., Frank R., Zhang J., Nimer S.D. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter. Oncogene. 18:1999;1015-1022.
119. Wade P.A., Pruss D., Wolffe A.P. Histone acetylation: chromatin in action. Trends Biochem. Sci. 22:1997;128-132.
120. Wang J., Hoshino T., Redner R.L., Kajigaya S., Liu J.M. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human NCoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. USA. 95:1998;10 860-10 865.
121. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA. 93:1996;3444-3449.
122. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bonies J.C., Alt F.W., Ryan G., Liu P.P., Wynshaw-Boris A., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell. 87:1996;697-708.
123. Wang S.W., Speck N.A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12:1992;89-102.
124. Wang S., Wang Q., Crute B.E., Melnikova I.N., Keller S.R., Speck N.A. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:1993;3324-3339.
125. Wargnier A., Legros-Maida S., Bosselut R., Bourge J.F., Lafaurie C., Ghysdael C.J., Sasportes M., Paul P. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc. Natl. Acad. Sci. USA. 92:1995;6930-6934.
126. Warrell R.P. Jr, He L.Z., Richon V., Calleja E., Pandolfi P.P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90:1998;1621-1625.
127. Westendorf J.J., Yamamoto C.M., Lenny N., Downing J.R., Selsted M.E., Hiebert S.W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBPα, inhibits C/EBPα-dependent transcription and blocks granulocytic differentiation. Mol. Cell. Biol. 18:1998;322-333.
128. Yagi R., Chen L.F., Shigesada K., Murakami Y., Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. Embo J. 18:1999;2551-2562.
129. Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., Zhang D.E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML-ETO fusion gene. Nat. Genet. 15:1997;303-306.
130. Zhang D.E., Fujioka K.I., Hetherington C.J., Shapiro L.H., Chen H.M., Look A.T., Tenen D.G. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14:1994;8085-8095.
131. Zhang D.E., Hetherington C.J., Meyers S., Rhoades K.L., Larson C.J., Chen H.M., Hiebert S.W., Tenen D.G. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16:1996;1231-1240.
132. Zhang D.E., Zhang P., Wang N.D., Hetherington C.J., Darlington G.J., Tenen D.G. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;569-574.
133. Zhang Y.W., Bae S.C., Huang G., Fu Y.X., Lu J., Ahn M.Y., Kanno Y., Kanno T., Ito Y. A novel transcript encoding an N-terminally truncated AML1/PEBP2αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Mol. Cell. Biol. 17:1997;4133-4145.